LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1057

Search options

  1. Article ; Online: Ruiz Ibáñez, José Javier, y Sabatini, Gaetano (eds.), 'La Inmaculada Concepción y la Monarquía Hispánica', Madrid, FCE y Red Columnaria, 2019. 334 págs. ISBN

    Rosilie Hernández

    Cuadernos de Historia Moderna, Vol 45, Iss

    978-84-375-0798-9.

    2020  Volume 2

    Keywords History (General) and history of Europe ; D ; Modern history ; 1453- ; D204-475
    Language Spanish
    Publishing date 2020-11-01T00:00:00Z
    Publisher Universidad Complutense de Madrid
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction era.

    Hernandez, Inmaculada

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

    2024  

    Abstract: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author ... ...

    Abstract In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
    Language English
    Publishing date 2024-04-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 1224627-x
    ISSN 1535-2900 ; 1079-2082
    ISSN (online) 1535-2900
    ISSN 1079-2082
    DOI 10.1093/ajhp/zxae104
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Net prices of new antiobesity medications.

    Hernandez, Inmaculada / Sullivan, Sean D

    Obesity (Silver Spring, Md.)

    2024  Volume 32, Issue 3, Page(s) 472–475

    Abstract: Objective: Glucagon-like peptide-1 receptor agonists (GLP1s) are effective antiobesity drugs and the subject of intense debate around insurance coverage due to the large prevalence of obesity and overweight. The estimation of the budget impact ... ...

    Abstract Objective: Glucagon-like peptide-1 receptor agonists (GLP1s) are effective antiobesity drugs and the subject of intense debate around insurance coverage due to the large prevalence of obesity and overweight. The estimation of the budget impact associated with GLP1 insurance coverage requires estimates of GLP1 prices that account for manufacturer discounts. The authors applied a peer-reviewed method to estimate the net prices of GLP1s after manufacturer discounts.
    Methods: The authors estimated manufacturer discounts for each product as the difference between the gross sales estimated at list price and manufacturer-reported revenue. From this difference, the authors subtracted discounts to government programs, including 340B, Medicaid, and the Medicare Part D coverage gap, and attributed the remaining amount to manufacturer discounts provided in the commercial market.
    Results: Manufacturer discounts for GLP1s approved for obesity were estimated at 41%, which translated into net prices of $717 to $761 per month of supply. Manufacturer discounts for GLP1s approved for type 2 diabetes ranged from 54% to 59%, which translated into net prices of $312 to $469 per month of supply.
    Conclusions: The magnitude of manufacturer discounts underscores the need to consider net price information in studies that inform private and public payers' decision-making around coverage of GLP1s for obesity.
    MeSH term(s) Aged ; United States ; Humans ; Medicare ; Diabetes Mellitus, Type 2/drug therapy ; Drug Costs ; Medicaid ; Obesity/drug therapy
    Language English
    Publishing date 2024-01-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2230457-5
    ISSN 1930-739X ; 1071-7323 ; 1930-7381
    ISSN (online) 1930-739X
    ISSN 1071-7323 ; 1930-7381
    DOI 10.1002/oby.23973
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Drugs likely subject to Medicare negotiation, 2026-2028.

    Dickson, Sean / Hernandez, Inmaculada

    Journal of managed care & specialty pharmacy

    2023  Volume 29, Issue 3, Page(s) 229–235

    Abstract: BACKGROUND: ...

    Abstract BACKGROUND:
    MeSH term(s) Aged ; Humans ; United States ; Biosimilar Pharmaceuticals ; Negotiating ; Medicare Part D ; Cost Sharing ; Hypoglycemic Agents ; Drugs, Generic
    Chemical Substances Biosimilar Pharmaceuticals ; Hypoglycemic Agents ; Drugs, Generic
    Language English
    Publishing date 2023-07-06
    Publishing country United States
    Document type Journal Article
    ISSN 2376-1032
    ISSN (online) 2376-1032
    DOI 10.18553/jmcp.2023.29.3.229
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A primer on brand-name prescription drug reimbursement in the United States.

    Hernandez, Inmaculada / Hung, Anna

    Journal of managed care & specialty pharmacy

    2023  Volume 30, Issue 1, Page(s) 99–106

    Abstract: Branded prescription drug reimbursement in the United States is complex and comprises multiple transactions among the parties involved in the drug supply chain, including manufacturers, wholesalers, pharmacies, health care providers, health plans or ... ...

    Abstract Branded prescription drug reimbursement in the United States is complex and comprises multiple transactions among the parties involved in the drug supply chain, including manufacturers, wholesalers, pharmacies, health care providers, health plans or insurers, pharmacy benefit managers, and patients. This primer provides an overview of the parties involved in the reimbursement of brand-name drugs under both the pharmacy and medical benefits of an insurance policy and the flow of products and payments among them. Prescription drug spending in the United States grew from $30 billion in 1980 to $335 billion in 2018, and 80% of spending is on brand-name drugs.
    MeSH term(s) Humans ; United States ; Prescription Drugs ; Drug Costs ; Pharmacies ; Insurance ; Health Planning ; Drugs, Generic
    Chemical Substances Prescription Drugs ; Drugs, Generic
    Language English
    Publishing date 2023-12-28
    Publishing country United States
    Document type Journal Article
    ISSN 2376-1032
    ISSN (online) 2376-1032
    DOI 10.18553/jmcp.2024.30.1.99
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Miettinen and Nurminen score statistics revisited.

    Martín Andrés, Antonio / Gayá Moreno, Francisco / Álvarez Hernández, María / Herranz Tejedor, Inmaculada

    Journal of biopharmaceutical statistics

    2024  , Page(s) 1–14

    Abstract: It is commonly necessary to perform inferences on the difference, ratio, and odds ratio of two ... ...

    Abstract It is commonly necessary to perform inferences on the difference, ratio, and odds ratio of two proportions
    Language English
    Publishing date 2024-02-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1131763-2
    ISSN 1520-5711 ; 1054-3406
    ISSN (online) 1520-5711
    ISSN 1054-3406
    DOI 10.1080/10543406.2024.2311242
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Nonfederal average manufacturer price to estimate savings generated by minimum discounts under the Inflation Reduction Act.

    Hernandez, Inmaculada / Gabriel, Nico / Dickson, Sean

    Journal of managed care & specialty pharmacy

    2023  Volume 29, Issue 11, Page(s) 1261–1263

    Abstract: DISCLOSURES: ...

    Abstract DISCLOSURES:
    Language English
    Publishing date 2023-10-27
    Publishing country United States
    Document type Letter
    ISSN 2376-1032
    ISSN (online) 2376-1032
    DOI 10.18553/jmcp.2023.29.11.1261
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Tolerant Epitypes of Elicited Holm Oak Somatic Embryos Could Be Revealed by Challenges in Dual Culture with

    Ruiz-Galea, Mar / Kremer, Carolina / Friero, Eva / Hernández, Inmaculada

    Plants (Basel, Switzerland)

    2023  Volume 12, Issue 17

    Abstract: Holm oaks ( ...

    Abstract Holm oaks (
    Language English
    Publishing date 2023-08-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2704341-1
    ISSN 2223-7747
    ISSN 2223-7747
    DOI 10.3390/plants12173056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: A Prescription for Achieving Equitable Access to Antiobesity Medications.

    Wright, Davene R / Guo, Jingchuan / Hernandez, Inmaculada

    JAMA health forum

    2023  Volume 4, Issue 4, Page(s) e230493

    MeSH term(s) Humans ; Anti-Obesity Agents/therapeutic use ; Obesity/drug therapy ; Prescriptions
    Chemical Substances Anti-Obesity Agents
    Language English
    Publishing date 2023-04-07
    Publishing country United States
    Document type Journal Article
    ISSN 2689-0186
    ISSN (online) 2689-0186
    DOI 10.1001/jamahealthforum.2023.0493
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Estimated discounts generated by Medicare drug negotiation in 2026.

    Hernandez, Inmaculada / Gabriel, Nico / Dickson, Sean

    Journal of managed care & specialty pharmacy

    2023  Volume 29, Issue 8, Page(s) 868–872

    Abstract: BACKGROUND: ...

    Abstract BACKGROUND:
    MeSH term(s) Aged ; United States ; Humans ; Medicare ; Negotiating ; Budgets ; Drug Costs
    Language English
    Publishing date 2023-07-29
    Publishing country United States
    Document type Journal Article
    ISSN 2376-1032
    ISSN (online) 2376-1032
    DOI 10.18553/jmcp.2023.29.8.868
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top